Zimmermann, B., Starke, G., Shaw, D., Elger, B. and Koné, I. (2020) “Actionability and scope should determine the extent of counselling for presymptomatic genetic testing”, Swiss Medical Weekly, 150(2728), p. w20274. doi: 10.4414/smw.2020.20274.